Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Cancer Warnings Over Roundup, Other Products Lead to U.S. Chemical Industry Calls To Rein in IARC January 26, 2017 Irvin Jackson Add Your CommentsChemistry industry lobbyists are calling for reforms to the World Health Organization’s (WHO) International Agency for Research on Cancer (IARC), indicating that recent warnings about the risk of cancer with Roundup and other commonly used products are unnecessarily frightening the public and based on questionable science.ย The American Chemistry Council (ACC) argues launched a Campaign for Accuracy in Public Health Research (CAPHR) this week, targeting the independent cancer group.The move by the chemical industry comes after the IARC decided to categorize glyohosate, the active ingredient in Monsanto’s widely used weedkiller Roundup, as probably a cancer-causing agent. The IARC has also made other controversial determinations regarding cancer risks associated with other products, such as hot beverages and red meats.ROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONWhile many health experts have support the cancer warnings, the chemical industry lobbying group issued a press release arguing that leading scientists have criticized the IARC monographs for scientific problem, as well as misleading and confusing the public.“The IARC Monographs Program has been responsible for countless misleading headlines about the safety of the food we eat, the jobs we do and the products we use in our daily lives,” Cal Dooley, ACC President and CEO, said in the press release. “By offering specific proposals for reform, the CAPHR hopes to play a constructive role in improving the IARC Monographs Program to ensure consumers, public health officials and regulators benefit from more credible and relevant information.”The campaign is the latest salvo fired at the IARC following its March 2015 determination that linked the use of Roundup weed killer to an increased risk of non-Hodgkin’s lymphoma, a form of cancer. The decision has sparked off scientific debate worldwide about the side effects of Roundup exposure as well as other IARC cancer determinations on things such as red meat, bacon and coffee.At issue in many cases is that the IARC does not generally weigh dose and exposure when making some cancer determinations, meaning that in some cases the risks are extremely small. However, the IARC holds that the risks are there and demonstrable.Chemical industry scientists and scientists representing other industries whose products could be affected by the rulings have called the IARC unfair and biased, but numerous independent scientists have risen to the group’s defense, saying industry groups are downplaying the risks of their products to make a profit.The ACC’s reform goals for the IARC include stronger requirements to consider dose and exposure, to put its findings in context of real-world use risks, changing how the IARC weighs evidence and which studies and data have the most weight in its determinations, establishing a standard criteria for selecting studies for analysis in its decisions, allowing more industry input, giving more data on potential conflicts of interest, and delaying the release of its monographs until it can release all available data and findings at once.Roundup Cancerย ConcernsLast month, the U.S. Environmental Protection Agency (EPA) held a four-day hearing on glyphosate safety, with a panel of scientific advisers questioning the agencyโs methodologies on determining that the weed killer was safe.The panel has 90 days to pour over the testimony, literature and evidence presented during the hearing, after which it will submit recommendations to the EPA. Those recommendations are non-binding, but usually have significant influence on the agencyโs final decisions.Monsanto now faces a growing number of Roundup cancer lawsuits filed throughout the United States, typically involving individuals diagnosed with a form of non-Hodgkinโs lymphoma following heavy exposure to the herbicide as a farm or agricultural worker. The complaints allege that the manufacturer recklessly promoted Roundup and pushed greater and greater use of the chemical, without disclosing the potential health risks.A recent U.S. Geological Survey on glyphosate usage nationwide foundย that an estimated 2.6 billion pounds of the herbicide has been sprayed on Americaโs agricultural land over the two decades since the mid-1990s, when Monsanto introduced โRoundup Readyโ crops that are designed to survive being sprayed with glyphosate, killing the weeds but not the crops.The lawsuits over Roundup allege that plaintiffs may have avoided a diagnosis of non-Hodgkinโs lymphoma or other cancers if they had been warned about the Roundup risks for farmers, landscapers and others in the agricultural industry, as safety precautions could have been taken or other products could have been used to control the growth of weeds. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Chemicals, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed KillerMore Roundup Lawsuit Stories U.S. Supreme Court Blocks Roundup Lawsuits Over Non-Hodgkin’s Lymphoma Warnings June 25, 2026 Roundup Class Action Lawsuit Linked to $7.2B NHL Settlement Transferred to Federal MDL June 2, 2026 MDL Judge Urged To Block $7.25B Roundup Non-Hodgkinโs Lymphoma Settlement April 28, 2026 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Bard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (Posted: 2 days ago)Plaintiffs and defendants have submitted a joint schedule for a final pretrial conference before the second Bard PowerPort lawsuit bellwether trial over claims the port catheter is defectively designed.MORE ABOUT: BARD POWERPORT LAWSUITNew Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026)Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (05/29/2026)Jury Returns Defense Verdict in First Bard PowerPort Injury Lawsuit (05/11/2026) Boston Scientific Spinal Cord Stimulator Lawyers to Meet With MDL Judge for Initial Conference Aug. 5 (Posted: 3 days ago)A federal judge appointed to oversee all federally consolidated Boston Scientific spinal cord stimulator lawsuits has called for an initial scheduling conference in early August.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITSpinal Cord Stimulator Lawsuit Claims Boston Scientific Sales Reps Made Unauthorized Device Adjustments (07/13/2026)Nevro SCS Lawsuits Warrant Centralization in New MDL: Motion (07/08/2026)Proclaim Spinal Cord Stimulator Lawsuit Follows Infection, Battery Migration Problems (07/06/2026) Breast Reconstruction Mesh Market Expands Despite Lawsuits Over Synthetic Mesh Failures (Posted: 4 days ago)Analysts expect wider use of breast reconstruction mesh through 2030, even as lawsuits raise questions about synthetic products, FDA approval and serious complications requiring additional surgery.MORE ABOUT: BREAST MESH LAWSUITGalaFLEX Mesh Problems May Lead Women To Require Breast Implant Removal Surgery (05/26/2026)Galaflex Breast Mesh Lawsuits Filed Against Becton Dickinson in Rhode Island (05/05/2026)Breast Mesh Implant Complications Often Leave Women Asking If They Have a Lawsuit (03/05/2026)
Bard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (Posted: 2 days ago)Plaintiffs and defendants have submitted a joint schedule for a final pretrial conference before the second Bard PowerPort lawsuit bellwether trial over claims the port catheter is defectively designed.MORE ABOUT: BARD POWERPORT LAWSUITNew Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026)Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (05/29/2026)Jury Returns Defense Verdict in First Bard PowerPort Injury Lawsuit (05/11/2026)
Boston Scientific Spinal Cord Stimulator Lawyers to Meet With MDL Judge for Initial Conference Aug. 5 (Posted: 3 days ago)A federal judge appointed to oversee all federally consolidated Boston Scientific spinal cord stimulator lawsuits has called for an initial scheduling conference in early August.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITSpinal Cord Stimulator Lawsuit Claims Boston Scientific Sales Reps Made Unauthorized Device Adjustments (07/13/2026)Nevro SCS Lawsuits Warrant Centralization in New MDL: Motion (07/08/2026)Proclaim Spinal Cord Stimulator Lawsuit Follows Infection, Battery Migration Problems (07/06/2026)
Breast Reconstruction Mesh Market Expands Despite Lawsuits Over Synthetic Mesh Failures (Posted: 4 days ago)Analysts expect wider use of breast reconstruction mesh through 2030, even as lawsuits raise questions about synthetic products, FDA approval and serious complications requiring additional surgery.MORE ABOUT: BREAST MESH LAWSUITGalaFLEX Mesh Problems May Lead Women To Require Breast Implant Removal Surgery (05/26/2026)Galaflex Breast Mesh Lawsuits Filed Against Becton Dickinson in Rhode Island (05/05/2026)Breast Mesh Implant Complications Often Leave Women Asking If They Have a Lawsuit (03/05/2026)